Company news
Phio Pharmaceuticals Corp. news in 2019
Phio Pharmaceuticals Corp.'s news releases, calls and decks from 2019, newest first.
Phio Pharmaceuticals Announces Adjournment of Special Meeting of Stockholders
December 12, 2019
Phio Pharmaceuticals and Karolinska Institutet Expand Collaboration to Develop Self-Delivering RNAi Immunotherapies for Treating Solid Tumors
November 20, 2019
Phio Pharmaceuticals Announces Closing of Public Offering of Common Stock
November 19, 2019
Phio Pharmaceuticals Announces Pricing of $1.0 Million Public Offering of Common Stock
November 17, 2019
Phio Pharmaceuticals Announces Proposed Public Offering of Common Stock
November 12, 2019
Phio Pharmaceuticals Announces Adjournment of 2019 Annual Meeting of Stockholders
October 10, 2019
Phio Pharmaceuticals Announces Research Collaboration with Carisma Therapeutics to Evaluate its Self-Delivering RNAi Technology to Enhance Macrophage-Based Adoptive Cell Therapy
September 8, 2019
Phio Pharmaceuticals Reports First Quarter 2019 Financial Results and Corporate Highlights
May 13, 2019
Phio Pharmaceuticals Appoints Dr. John Barrett as Chief Development Officer
April 9, 2019